Basilard BioTech Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
11
Basilard BioTech General Information
Description
Developer of a nanomechanical gene delivery platform designed to transform the growing cell-based therapies market. The company's tool offers a mechanical rather than a biological approach to gene delivery by consistently achieving transfection, cell viability performance, and yields, enabling clients to improve their cell therapeutic results.
Contact Information
Website
www.basilardbio.comCorporate Office
- 41593 Winchester Road
- Suite 200
- Temecula, CA 92590
- United States
Corporate Office
- 41593 Winchester Road
- Suite 200
- Temecula, CA 92590
- United States
Basilard BioTech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Accelerator/Incubator | 22-Jan-2026 | Completed | Generating Revenue | |||
| 8. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 7. Accelerator/Incubator | 01-Jan-2023 | Completed | Generating Revenue | |||
| 6. Early Stage VC | 01-Feb-2022 | Completed | Generating Revenue | |||
| 5. Seed Round | 20-Oct-2021 | Completed | Generating Revenue | |||
| 4. Seed Round | 01-Dec-2020 | Completed | Generating Revenue | |||
| 3. Seed Round | 02-Mar-2020 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. University Spin-Out | 01-Jul-2019 | Completed | Startup |
Basilard BioTech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Basilard BioTech Patents
Basilard BioTech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260265664-A1 | Fabrication methods for deterministic mechanoporation gene delivery devices and systems | Pending | 07-Apr-2023 | ||
| WO-2024211609-A1 | Fabrication methods for deterministic mechanoporation gene delivery devices and systems | Inactive | 07-Apr-2023 | ||
| EP-4519019-A1 | Deterministic mechanoporation devices, systems and methods | Pending | 03-May-2022 | ||
| EP-4519019-A4 | Deterministic mechanoporation devices, systems and methods | Pending | 03-May-2022 | ||
| US-20250263750-A1 | Deterministic mechanoporation devices, systems and methods | Pending | 03-May-2022 | C12N15/87 |
Basilard BioTech Signals
Basilard BioTech Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| UCR EPIC Innovation & Entrepreneurship Programs | Accelerator/Incubator | |||
| CONNECT (San Diego) | Accelerator/Incubator | |||
| Band of Angels | Angel Group | Minority | ||
| Life Science Angels | Angel Group | Minority | ||
| SeedFolio | Venture Capital | Minority |
Basilard BioTech FAQs
-
When was Basilard BioTech founded?
Basilard BioTech was founded in 2019.
-
Where is Basilard BioTech headquartered?
Basilard BioTech is headquartered in Temecula, CA.
-
What is the size of Basilard BioTech?
Basilard BioTech has 5 total employees.
-
What industry is Basilard BioTech in?
Basilard BioTech’s primary industry is Drug Delivery.
-
Is Basilard BioTech a private or public company?
Basilard BioTech is a Private company.
-
What is Basilard BioTech’s current revenue?
The current revenue for Basilard BioTech is .
-
How much funding has Basilard BioTech raised over time?
Basilard BioTech has raised $8.25M.
-
Who are Basilard BioTech’s investors?
UCR EPIC Innovation & Entrepreneurship Programs, CONNECT (San Diego), Band of Angels, Life Science Angels, and SeedFolio are 5 of 11 investors who have invested in Basilard BioTech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process